TrialRadiation oncology (London, England)2023

A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy.

Xiaoli Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.